Burney Co. Purchases New Holdings in Liquidia Corporation $LQDA

Posted by on Jul 9th, 2026

Burney Co. purchased a new position in shares of Liquidia Corporation (NASDAQ:LQDA – Free Report) during the first quarter, Holdings Channel reports. The firm purchased 48,481 shares of the company’s stock, valued at approximately $1,830,000.

A number of other hedge funds have also recently added to or reduced their stakes in the stock. Northwestern Mutual Wealth Management Co. acquired a new position in Liquidia in the 4th quarter valued at $25,000. Covestor Ltd lifted its position in shares of Liquidia by 41.9% during the 4th quarter. Covestor Ltd now owns 1,216 shares of the company’s stock valued at $42,000 after acquiring an additional 359 shares during the period. FNY Investment Advisers LLC acquired a new stake in shares of Liquidia during the 3rd quarter worth $34,000. NewEdge Advisors LLC acquired a new stake in shares of Liquidia during the 2nd quarter worth $25,000. Finally, Hurley Capital LLC increased its position in shares of Liquidia by 140.7% in the fourth quarter. Hurley Capital LLC now owns 5,200 shares of the company’s stock worth $179,000 after purchasing an additional 3,040 shares during the period. Institutional investors own 64.54% of the company’s stock.

Insider Activity at Liquidia

In related news, insider Sarah Krepp sold 24,880 shares of the company’s stock in a transaction that occurred on Thursday, June 11th. The shares were sold at an average price of $70.28, for a total transaction of $1,748,566.40. Following the completion of the transaction, the insider directly owned 121,863 shares in the company, valued at $8,564,531.64. This represents a 16.95% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Stephen M. Bloch sold 50,000 shares of the stock in a transaction that occurred on Tuesday, July 7th. The shares were sold at an average price of $80.94, for a total transaction of $4,047,000.00. Following the completion of the transaction, the director directly owned 780,073 shares of the company’s stock, valued at approximately $63,139,108.62. The trade was a 6.02% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 2,243,241 shares of company stock worth $134,648,225 over the last ninety days. 25.60% of the stock is currently owned by insiders.

Analysts Set New Price Targets

LQDA has been the subject of a number of analyst reports. BTIG Research boosted their price target on Liquidia from $59.00 to $109.00 and gave the company a “buy” rating in a research note on Monday, June 22nd. Jefferies Financial Group reiterated a “buy” rating and set a $60.00 price objective on shares of Liquidia in a research note on Monday, May 11th. Wells Fargo & Company raised their target price on shares of Liquidia from $51.00 to $62.00 and gave the company an “overweight” rating in a report on Tuesday, May 12th. Weiss Ratings restated a “sell (d-)” rating on shares of Liquidia in a research report on Tuesday, April 21st. Finally, Oppenheimer set a $75.00 price target on shares of Liquidia in a report on Friday, June 5th. Three equities research analysts have rated the stock with a Strong Buy rating, five have issued a Buy rating, one has given a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $68.88.

Read Our Latest Analysis on Liquidia

Liquidia Stock Performance

NASDAQ:LQDA opened at $79.47 on Thursday. Liquidia Corporation has a twelve month low of $12.88 and a twelve month high of $82.96. The company has a quick ratio of 2.03, a current ratio of 2.22 and a debt-to-equity ratio of 1.18. The stock’s 50-day simple moving average is $63.33 and its 200 day simple moving average is $46.35. The firm has a market capitalization of $7.07 billion, a PE ratio of 567.68 and a beta of 0.55.

Liquidia (NASDAQ:LQDA – Get Free Report) last issued its earnings results on Monday, May 11th. The company reported $0.52 EPS for the quarter, topping the consensus estimate of $0.41 by $0.11. The firm had revenue of $132.87 million during the quarter, compared to the consensus estimate of $119.44 million. Liquidia had a return on equity of 46.82% and a net margin of 7.74%.The business’s revenue was up 4187.1% on a year-over-year basis. On average, analysts anticipate that Liquidia Corporation will post 3.02 EPS for the current fiscal year.

About Liquidia

(Free Report)

Liquidia Technologies, Inc is a clinical-stage biopharmaceutical company headquartered in Research Triangle Park, North Carolina. The company leverages its proprietary PRINT® (Particle Replication In Non-wetting Templates) platform to engineer precisely shaped and sized drug particles, with the goal of improving delivery, efficacy and safety profiles. By controlling particle characteristics at the nanoscale, Liquidia seeks to enhance respiratory and other therapies that depend on targeted delivery.

The company’s lead product candidate, LIQ861, is a dry powder formulation of treprostinil designed for inhalation in patients with pulmonary arterial hypertension (PAH).

Read More

Want to see what other hedge funds are holding LQDA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Liquidia Corporation (NASDAQ:LQDA – Free Report).

Institutional Ownership by Quarter for Liquidia (NASDAQ:LQDA)

Receive News & Ratings for Liquidia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Liquidia and related companies with MarketBeat.com's FREE daily email newsletter.